Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.
H Jin, … , R W Scott, J B Baker
H Jin, … , R W Scott, J B Baker
Published April 1, 1995
Citation Information: J Clin Invest. 1995;95(4):1947-1952. https://doi.org/10.1172/JCI117877.
View: Text | PDF
Research Article

Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.

  • Text
  • PDF
Abstract

Bactericidal/permeability-increasing protein (BPI) is a neutrophil primary granule protein that inhibits effects of LPS in vitro. The current study examined the effects of BPI on hemodynamics, mortality, and circulating endotoxin and cytokines in conscious rats with endotoxic shock. Catheters were implanted into the right femoral artery and vein. 1 d later, human recombinant BPI (10 mg/kg) or vehicle was intravenously injected immediately, 30 min, or 2 h after intravenous injection of LPS (7.5 mg/kg). Mean arterial pressure (MAP) and heart rate were monitored and blood was collected before and after injection. BPI given immediately or 30 min after LPS prevented the LPS-induced reduction in MAP at 4-8 h and markedly reduced mortality. BPI given 2 h after LPS injection had no protective effect. BPI treated immediately after LPS reduced the circulating levels of endotoxin and IL-6 but increased the circulating levels of TNF. We propose that BPI exerts its protective effect through a TNF-independent mechanism, by inhibiting endotoxin-stimulated production of IL-6.

Authors

H Jin, R Yang, S Marsters, A Ashkenazi, S Bunting, M N Marra, R W Scott, J B Baker

×

Total citations by year

Year: 2022 2016 2015 2011 2010 2008 2007 2004 2003 2001 2000 1998 1997 1996 Total
Citations: 1 1 1 1 1 1 3 2 2 3 2 1 2 2 23
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (23)

Title and authors Publication Year
A Polymorphism of Bactericidal/Permeability-Increasing Protein Affects Its Neutralization Efficiency towards Lipopolysaccharide
K Ederer, J Holzinger, K Maier, L Zeller, M Werner, M Toelge, A Gessner, S Bülow
International journal of molecular sciences 2022
Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock
A Balakrishnan, P DasSarma, O Bhattacharjee, JM Kim, S DasSarma, D Chakravortty
Scientific Reports 2016
Pilot experience with opebacan/rBPI21 in myeloablative hematopoietic cell transplantation
E Guinan, DE Avigan, RJ Soiffer, NJ Bunin, LL Brennan, I Bergelson, S Brightman, A Ozonoff, PJ Scannon, O Levy
F1000Research 2015
Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death
EC Guinan, CM Barbon, LA Kalish, K Parmar, J Kutok, CJ Mancuso, L Stoler-Barak, EE Suter, JD Russell, CD Palmer, LC Gallington, A Voskertchian, JA Vergilio, G Cole, K Zhu, A D’Andrea, R Soiffer, JP Weiss, O Levy
Science Translational Medicine 2011
Increased bactericidal/permeability increasing protein in patients with cirrhosis
A Guerra-Ruiz, F Casafont, M Cobo, A TerÃn, JÃ de-la-PeÃa, A Estebanez, F Pons-Romero
Liver International 2010
Murine Bactericidal/Permeability-Increasing Protein Inhibits the Endotoxic Activity of Lipopolysaccharide and Gram-Negative Bacteria
I Wittmann, M Schönefeld, D Aichele, G Groer, A Gessner, M Schnare
Journal of immunology (Baltimore, Md. : 1950) 2008
Wilderness Medicine
PH Hackett, RC Roach
Wilderness Medicine 2007
Bactericidal/permeability increasing protein attenuates the myocardial inflammation/dysfunction that occurs with burn complicated by subsequent infection
JW Horton, DL Maass, DJ White, JP Minei
Journal of applied physiology 2007
Isolation, Cloning, and Characterization of a Novel Phosphomannan-binding Lectin from Porcine Serum
BY Ma, N Nakamura, V Dlabac, H Naito, S Yamaguchi, M Ishikawa, M Nonaka, M Ishiguro, N Kawasaki, S Oka, T Kawasaki
The Journal of biological chemistry 2007
Antagonistic antibody prevents toll-like receptor 2 driven lethal shock-like syndromes
Guangxun Meng, Mark Rutz, Matthias Schiemann, Jochen Metzger, Alina Grabiec, Ralf Schwandner, Peter B. Luppa, Frank Ebel, Dirk H. Busch, Stefan Bauer, Hermann Wagner, Carsten J. Kirschning
Journal of Clinical Investigation 2004
Dual Receptors and Distinct Pathways Mediate Interleukin-1 Receptor-associated Kinase Degradation in Response to Lipopolysaccharide: INVOLVEMENT OF CD14/TLR4, CR3, AND PHOSPHATIDYLINOSITOL 3-KINASE
S Noubir, Z Hmama, NE Reiner
The Journal of biological chemistry 2004
Anti-inflammatory strategies for the treatment of sepsis
NC Riedemann, PA Ward
Expert Opinion on Biological Therapy 2003
A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice
MG Vallespi, JC Alvarez-Obregón, I Rodriguez-Alonso, T Montero, H Garay, O Reyes, MJ Araña
International Immunopharmacology 2003
Recombinant Bactericidal/Permeability-Increasing Protein (rBPI21) for Treatment of Parvovirus Enteritis: A Randomized, Double-Blinded, Placebo-Controlled Trial
CM Otto, CB Jackson, EJ Rogell, RB Prior, WS Ammons
Journal of Veterinary Internal Medicine 2001
Human Endotoxemia Activates p38 MAP Kinase and p42/44 MAP Kinase, But Not c-Jun N-terminal Kinase
B van den Blink, J Branger, S Weijer, SJ van Deventer, T van der Poll, MP Peppelenbosch
Molecular Medicine 2001
Role of the Classical Pathway of Complement Activation in Experimentally Induced Polymicrobial Peritonitis
JD Clements, I Celik, C Stover, M Botto, S Thiel, S Tzima, D Künkel, M Walport, W Lorenz, W Schwaeble
Infection and immunity 2001
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins
JR Rose, MA Mullarkey, WJ Christ, LD Hawkins, M Lynn, Y Kishi, KM Wasan, K Peteherych, DP Rossignol
Antimicrobial agents and chemotherapy 2000
Myocarditis
AM Feldman, D McNamara
New England Journal of Medicine 2000
Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model
T Sawa, K Kurahashi, M Ohara, MA Gropper, V Doshi, JW Larrick, JP Wiener-Kronish
Antimicrobial agents and chemotherapy 1998
A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats
DJ Brackett, MR Lerner, MA Lacquement, R He, HA Pereira
Infection and immunity 1997
Life-Threatening Coagulation Disorders in Critical Care Medicine
V Hach-Wunderle, PP Nawroth
1997
Biochemistry and cell biology of bacterial endotoxins
O Holst, AJ Ulmer, H Brade, HD Flad, ET Rietschel
FEMS Immunology & Medical Microbiology 1996
Lebensbedrohliche Gerinnungsstörungen in der Intensivmedizin
V Hach-Wunderle, PP Nawroth
1996

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts